ClinicalTrials.Veeva

Menu
N

Neurobehavioral Research | Cedarhurst, NY

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lurasidone
Cariprazine
BI 409306
RO7795081
Azetukalner
BI 1358894
BI 1569912
BMS-820836
BHV-7000
Agomelatine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 68 total trials

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity (CANYON-1)

This study will assess the safety of the investigational drug CRB-913 and how it is processed in the body.The study has two parts: Part 1 will measur...

Enrolling
Obese But Otherwise Healthy Participants
Drug: CRB-913
Drug: Placebo

The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel....

Enrolling
Major Depressive Disorder
Drug: Zelquistinel

This study is open to people aged 18 years or older with schizophrenia. People can join the study if they are willing to use a smartphone app called...

Active, not recruiting
Schizophrenia
Device: Digital therapeutic (CT-155)

X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult part...

Enrolling
Bipolar II Disorder
Bipolar I Disorder
Drug: Placebo
Drug: Azetukalner

This multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tol...

Active, not recruiting
Obesity or Overweight
Drug: RO7795081
Drug: Placebo

This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

X-CEED-OLE is a Phase 3, multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner in adult participa...

Invitation-only
Bipolar II Disorder
Bipolar I Disorder
Drug: Azetukalner

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population in the United States. The purpose of this study is t...

Enrolling
Bipolar I or II Disorder
Drug: ABBV-932

The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel....

Enrolling
Major Depressive Disorder
Drug: Zelquistinel

Trial sponsors

Boehringer Ingelheim logo
Sumitomo Pharma logo
AbbVie logo
Bristol-Myers Squibb (BMS) logo
Otsuka logo
Pfizer logo
Roche logo
X
S
Biohaven logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems